Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trialRupert Bartsch, Matthias Preusser, Georg Widhalm et al.|Nature Medicine|2022Cited by 395
Activity of T-DM1 in Her2-positive breast cancer brain metastasesRupert Bartsch, Matthias Preusser, Anna S. Berghoff et al.|Clinical & Experimental Metastasis|2015Cited by 122
Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastasesRupert Bartsch, Matthias Preusser, Anna S. Berghoff et al.|Neuro-Oncology|2024Cited by 60
Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell linesYvonne Bader, Thomas Szekeres, Johannes Hartmann et al.|Cancer Letters|2007Cited by 19
Abstract P6-16-10: Activity of T-DM1 in HER2-positive breast cancer brain metastasesRupert Bartsch, Matthias Preusser, Anna S. Berghoff et al.|Cancer Research|2015Cited by 3